The Food and Drug Administration today published a proposed rule that would update requirements under the Mammography Quality Standards Act of 1992, which authorized FDA oversight of mammography facilities. According to the agency, the rule would expand the information that mammography facilities must provide to patients and health care professionals, modernize mammography quality standards and enhance facility oversight. For example, the rule would require that the facility report information on breast density in the report to the clinician and the patient’s summary letter to enable patients and their doctors to have a more informed discussion about the enhanced risks associated with dense breasts if appropriate. The agency will accept comments on the proposed rule for 90 days.

Related News Articles

Blog
America’s hospitals and health systems are dedicated to doing everything possible for patients, particularly when they need emergency care and as a place for…
Headline
Hospitals, health systems and other health care organizations can sign up this week to host an intern for this year's Institute for Diversity and Health Equity…
Headline
The Centers for Disease Control and the National Tuberculosis Controllers Association this week released updated recommendations for TB screening and testing…
Headline
The House Ways and Means Committee today held a hearing examining the impact of racial disparities and social determinants of health on maternal mortality.
Headline
The Centers for Medicare…
Headline
The Food and Drug Administration last week alerted health care providers and patients that batteries in certain Medtronic implantable pacemakers and cardiac…